220 related articles for article (PubMed ID: 19902332)
1. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants.
Piecha D; Weik J; Kheil H; Becher G; Timmermann A; Jaworski A; Burger M; Hofmann MW
Inflamm Res; 2010 May; 59(5):379-89. PubMed ID: 19902332
[TBL] [Abstract][Full Text] [Related]
2. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
[TBL] [Abstract][Full Text] [Related]
4. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
5. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
6. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
7. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13.
Li NG; Shi ZH; Tang YP; Wang ZJ; Song SL; Qian LH; Qian DW; Duan JA
Curr Med Chem; 2011; 18(7):977-1001. PubMed ID: 21254976
[TBL] [Abstract][Full Text] [Related]
8. Gumiganghwal-tang ameliorates cartilage destruction via inhibition of matrix metalloproteinase.
Kim MH; Choi Y; Ahn KS; Um JY; Lee SG; Hahm DH; Yang WM
J Ethnopharmacol; 2020 Oct; 261():113074. PubMed ID: 32534115
[TBL] [Abstract][Full Text] [Related]
9. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
[TBL] [Abstract][Full Text] [Related]
12. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
13. In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage.
Freemont AJ; Byers RJ; Taiwo YO; Hoyland JA
Ann Rheum Dis; 1999 Jun; 58(6):357-65. PubMed ID: 10340960
[TBL] [Abstract][Full Text] [Related]
14. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
15. IL-37 diminishes proteoglycan loss in human OA cartilage: donor-specific link between IL-37 and MMP-3.
van Geffen EW; van Caam APM; Schreurs W; van de Loo FA; van Lent PLEM; Koenders MI; Thudium CS; Bay-Jensen AC; Blaney Davidson EN; van der Kraan PM
Osteoarthritis Cartilage; 2019 Jan; 27(1):148-157. PubMed ID: 30201492
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
17. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
[TBL] [Abstract][Full Text] [Related]
18. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.
Hu Q; Ecker M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572320
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis.
Xu L; Peng H; Glasson S; Lee PL; Hu K; Ijiri K; Olsen BR; Goldring MB; Li Y
Arthritis Rheum; 2007 Aug; 56(8):2663-73. PubMed ID: 17665456
[TBL] [Abstract][Full Text] [Related]
20. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
